TrialBone marrow transplantation2019
Outcome of allografting for AML-CR2 is equivalent across BSBMT and EBMT and is associated with encouraging OS and DFS across all age groups.
Jenny Byrne et al.PubMed ↗Publisher ↗
No numbers read from the abstract.